Correlation Between Inhibrx and Keros Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Keros Therapeutics, you can compare the effects of market volatilities on Inhibrx and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Keros Therapeutics.
Diversification Opportunities for Inhibrx and Keros Therapeutics
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Inhibrx and Keros is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Inhibrx i.e., Inhibrx and Keros Therapeutics go up and down completely randomly.
Pair Corralation between Inhibrx and Keros Therapeutics
Given the investment horizon of 90 days Inhibrx is expected to generate 0.25 times more return on investment than Keros Therapeutics. However, Inhibrx is 3.96 times less risky than Keros Therapeutics. It trades about -0.09 of its potential returns per unit of risk. Keros Therapeutics is currently generating about -0.18 per unit of risk. If you would invest 1,486 in Inhibrx on October 26, 2024 and sell it today you would lose (184.00) from holding Inhibrx or give up 12.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Keros Therapeutics
Performance |
| Timeline |
| Inhibrx |
| Keros Therapeutics |
Inhibrx and Keros Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Keros Therapeutics
The main advantage of trading using opposite Inhibrx and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |